Free Trial

Dodge & Cox Has $4.43 Billion Stock Position in MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

Dodge & Cox reduced its stake in MetLife, Inc. (NYSE:MET - Free Report) by 0.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 54,154,554 shares of the financial services provider's stock after selling 502,027 shares during the quarter. MetLife accounts for 2.6% of Dodge & Cox's investment portfolio, making the stock its 6th largest position. Dodge & Cox owned 7.82% of MetLife worth $4,434,175,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Retirement Wealth Solutions LLC purchased a new position in shares of MetLife during the fourth quarter worth about $32,000. Sierra Ocean LLC acquired a new stake in shares of MetLife in the 4th quarter valued at about $32,000. Graney & King LLC acquired a new position in MetLife during the fourth quarter worth approximately $34,000. Values First Advisors Inc. purchased a new stake in MetLife in the fourth quarter valued at approximately $36,000. Finally, Golden State Wealth Management LLC acquired a new stake in shares of MetLife in the fourth quarter valued at approximately $44,000. Institutional investors and hedge funds own 94.99% of the company's stock.

MetLife Stock Performance

MET traded up $0.79 on Friday, hitting $72.49. 2,739,216 shares of the company's stock were exchanged, compared to its average volume of 3,404,801. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. The stock has a fifty day moving average of $79.41 and a two-hundred day moving average of $82.19. The firm has a market cap of $49.38 billion, a PE ratio of 12.14, a P/E/G ratio of 0.65 and a beta of 0.89. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $89.05.

MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, research analysts anticipate that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. JPMorgan Chase & Co. lowered their price target on MetLife from $88.00 to $86.00 and set an "overweight" rating on the stock in a report on Wednesday, April 2nd. Keefe, Bruyette & Woods dropped their price objective on shares of MetLife from $98.00 to $95.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Morgan Stanley reduced their target price on shares of MetLife from $109.00 to $94.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Piper Sandler boosted their price target on shares of MetLife from $92.00 to $94.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Finally, BMO Capital Markets began coverage on shares of MetLife in a research report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 price objective for the company. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. According to MarketBeat, MetLife presently has an average rating of "Moderate Buy" and a consensus target price of $92.46.

View Our Latest Report on MetLife

About MetLife

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should You Invest $1,000 in MetLife Right Now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines